MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcchd.2026.100656

Медицинская библиотека · International journal of cardiology. Congenital heart disease · 2026

Clinical worsening in adult congenital heart disease and heart failure: A single-centre, observational study.

Bourgeois Thibault, Hubert Juliette, De Meester Pieter, Petit Thibault, Troost Els, Van Aelst Lucas, Rega Filip, Moons Philip, Budts Werner, Van De Bruaene Alexander

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Data on contemporary treatment approaches and reliable markers of clinical worsening in adult patients with congenital heart disease and heart failure (ACHD-HF) are scarce. This study aimed at evaluating (1) medical therapy within a contemporary ACHD-HF cohort and (2) the incidence of various (composite) endpoints across anatomical and pathophysiological subgroups.

METHODS

Retrospective study including ACHD-HF patients (≥16 years) under active follow-up at a tertiary care center, monitored until last visit, death, ventricular assist device (VAD) implantation, or heart transplant (HTX). Medical therapy was documented at time of inclusion and final follow-up. Clinical endpoints were evaluated, after excluding patients with early events (<1 week of inclusion) or without follow-up. Endpoints included HF hospitalization, increase of diuretic treatment, NYHA class progression, all-cause mortality, HTX and VAD placement.

RESULTS

Of the 256 ACHD-HF patients (mean age 50 ± 17 years; 52 % male), 56 were excluded for the final analysis. Two hundred patients were followed for a median of 30 (IQR 22-36) months. Changes in medical therapy included: increased use of mineralocorticoid receptor antagonists (p = 0.038), sodium-glucose transport protein 2 inhibitors (p = 0.002) and a trend towards increased use of angiotensin receptor-neprilysin inhibitors (p = 0.070). Furthermore, whereas HF hospitalization (p < 0.001) and progression of NYHA (p = 0.016) were associated with death, whereas HTX or VAD implant and escalation of diuretic therapy (p = 0.961) were not.

CONCLUSIONS

This study characterizes current ACHD-HF therapy and identifies NYHA progression and HF hospitalization as potential markers of clinical worsening as they relate to death, HTX, and VAD implantation.

Для цитирования: Bourgeois Thibault, Hubert Juliette, De Meester Pieter, Petit Thibault, Troost Els, Van Aelst Lucas, Rega Filip, Moons Philip, Budts Werner, Van De Bruaene Alexander. Clinical worsening in adult congenital heart disease and heart failure: A single-centre, observational study.. International journal of cardiology. Congenital heart disease. 2026. DOI: 10.1016/j.ijcchd.2026.100656.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.